GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » Operating Margin %

Zentiva (BSE:SCD) Operating Margin % : 22.19% (As of Mar. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Zentiva's Operating Income for the three months ended in Mar. 2025 was lei60 Mil. Zentiva's Revenue for the three months ended in Mar. 2025 was lei271 Mil. Therefore, Zentiva's Operating Margin % for the quarter that ended in Mar. 2025 was 22.19%.

Good Sign:

Zentiva SA operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Zentiva's Operating Margin % or its related term are showing as below:

BSE:SCD' s Operating Margin % Range Over the Past 10 Years
Min: 13.94   Med: 19.42   Max: 68.76
Current: 22.87


BSE:SCD's Operating Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 6.9 vs BSE:SCD: 22.87

Zentiva's 5-Year Average Operating Margin % Growth Rate was 9.90% per year.

Zentiva's Operating Income for the three months ended in Mar. 2025 was lei60 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was lei256 Mil.


Zentiva Operating Margin % Historical Data

The historical data trend for Zentiva's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva Operating Margin % Chart

Zentiva Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.94 17.44 14.04 21.40 24.32

Zentiva Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.24 24.66 23.85 20.82 22.19

Competitive Comparison of Zentiva's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Zentiva's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentiva's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zentiva's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Zentiva's Operating Margin % falls into.


;
;

Zentiva Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Zentiva's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=270.915 / 1114.065
=24.32 %

Zentiva's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=60.214 / 271.35
=22.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentiva  (BSE:SCD) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Zentiva Operating Margin % Related Terms

Thank you for viewing the detailed overview of Zentiva's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentiva Business Description

Traded in Other Exchanges
N/A
Address
No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.